GSK PLC Sponsored ADR (NYSE: GSK - Get Free Report) has received a consensus recommendation of "Hold

H2 2026/Q1 2027 will be rich in catalysts. From the potential FDA approval of bepirovirsen, with a t

SAN FRANCISCO--(BUSINESS WIRE)-- #GSK--Noetik achieves first milestone in landmark GSK collaboration

Two unvaccinated Pennsylvania residents died of measles, the state’s first deaths in 35 years, as tr

GSK's Jemperli gets FDA priority review for dMMR/MSI-H rectal cancer with a decision due in February

GSK said on Monday its experimental chronic hepatitis B drug received its first global approval in J

Oz says the MMR vaccine is “not a lethal vaccine” after Trump warned the combined shot could be “qui

GSK PLC (LSE:GSK, NYSE:GSK) got a grudging nod from Citi on Thursday, as the investment bank lifted

GSK PLC (LSE:GSK, NYSE:GSK) got a grudging nod from Citi on Thursday, as the investment bank lifted

On August 19, 2026, GSK PLC (GSK) shares rose 3.4% to a current price of $52.88. The stock has exper

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

President Donald Trump's latest executive order calls for splitting the measles, mumps and rubella,

During market turbulence, investors turn to dividend-yielding stocks. Benzinga provides analyst rati

President Donald Trump signed an order Monday limiting core childhood vaccine recommendations to 11

https://youtu.be/H_RititNE8U

The Trump administration is reportedly considering an executive order on vaccines and autism as earl

Vaccine maker GlaxoSmithKline Pharmaceuticals reported a 15.7% rise in first-quarter profit on Monda

British biotech firm Relation Therapeutics said on Wednesday it ​had entered into a research ‌collab

GSK beats Q2 earnings and revenue estimates, reaffirms 2026 guidance and unveils a new cost-saving p

https://www.gsk.com/en-gb/media/press-releases/cabenuva-demonstrates-superiority-to-daily-oral-thera

GSK plc (GSK) Q2 2026 Earnings Call Transcript

GSK NYSE: GSK reported second-quarter sales growth of 5% at constant exchange rates to more than £8.

GSK beats Q2 revenue and earnings estimates, launches a $2.52B cost-savings program, and updates its

GSK delivered healthy Q2 and H1 2026 results, with the highlight being core turnover and EPS growth

GSK PLC (LSE:GSK, NYSE:GSK) shares jumped to a three-month high after the drugmaker beat second-quar

GSK PLC (LSE:GSK, NYSE:GSK) shares jumped to a three-month high after the drugmaker beat second-quar

U.S. stocks mixed, Dow Jones up 300 points. Shares of Sherwin-Williams rose 7.8% after reporting bet

GSK (GSK) came out with quarterly earnings of $1.36 per share, beating the Zacks Consensus Estimate

The U.K. drugmaker is targeting annual savings of $2.52 billion by 2029, as Chief Executive Luke Mie

In times of market turbulence, dividend-yielding stocks are popular for investors. Check out analyst

GSK (NYSE:GSK) affirms FY2026 Adj EPS guidance from $4.90-$5.00 to $4.90-$5.00 vs $4.79 analyst esti

GSK (NYSE:GSK) reported quarterly earnings of $1.35 per share which beat the analyst consensus estim

Results add to a growing body of positive late-stage evidence for Ris-Rez, including recent pivotal

GSK on Tuesday ​beat second-quarter profit ‌expectations and launched a £1.9 ​billion ($2.52 billion

GSK Canada today announced the approval of Shingrix (GSK's Recombinant Zoster Vaccine or RZV) in

GSK wins early FDA approval for Jideytro, a targeted treatment for adults with advanced ROS1-positiv

GSK plc (LSE/NYSE:GSK) today announced the US Food and Drug Administration (FDA) has approved Jideyt

Trump says imported generic drugs face 0% tariffs for 2 years, before 100% and then 200% duties.

GSK stops development of chronic cough drug camlipixant after mixed Phase 3 results; continue testin

Investors turn to dividend-yielding stocks during market turbulence. Benzinga's Analyst Stock Ra

GSK Jemperli shows sustained complete responses in dMMR/MSI-H rectal cancer, potentially eliminating

GSK-backed Ris-Rez posts positive Phase 3 survival data in small-cell lung cancer as the company mov

Hansoh Pharmaceutical Group Co., Ltd. (Hansoh Pharma, 03692.HK) today announces that risvutatug reze

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Sino Biopharma expanded its GSK partnership in China and signed an AstraZeneca licensing deal worth

Elizabeth Warren warns Trump's law pushed children off Medicaid and CHIP in many states, while a

Investors turn to dividend-yielding stocks in turbulent markets. Benzinga offers latest analyst rati

FDA approves GSK and SPRO's Utebzi, the first oral carbapenem for cUTIs. Launch planned for late

https://www.gsk.com/en-gb/media/press-releases/utebzi-tebipenem-pivoxil-approved-in-the-us-for-adult

GSK announced today that Health Canada has approved Exdensur (depemokimab) for two indications:As an